← Eichor
Study identifier: NCT06982469 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

High Dose Rate (HDR) Brachytherapy Salvage After Prostatectomy

Condition: Prostate Cancer · Prostatectomy · Local Recurrence of Malignant Tumor of Prostate  ·  Sponsor: Clinica Universidad de Navarra, Universidad de Navarra

PhaseN/A
Planned participants20
Who can joinMale, 18 Years to 80 Years
Healthy volunteersNo

About this study

The goal of this observational study is to learn about the long-term effects of HDR Brachytherapy in men with isolated local relapses after radical prostatectomy. The main question it aims to answer is: Does HDR Brachytherapy increase control rates and decreases complications compared with conventional External Irradiation? Participants will be asked to receive HDR brachytherapy as part of their regular medical care for isolated local relapses after radical prostatectomy

This description comes directly from the study's public registry record.

Talk to the study team

Gabriel Canel, Ph.D.  ·  948255400  ·  gcanel@unav.es

Always discuss trial participation with your own doctor first.

Locations (1)

Clínica Universidad de NavarraPamplona, Foral Community of Navarre, SpainRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06982469